<DOC>
	<DOCNO>NCT00929955</DOCNO>
	<brief_summary>There evidence anti-inflammatory treatment may beneficial effect schizophrenia major depression . Cox-2 inhibitor test preliminary clinical trial schizophrenia depression , show favourable effect compare placebo ( Muller Schwarz et al 2009 ) . Statins introduce cholesterol-lowering agent find much wide usage . They anti-inflammatory agent thus similar Cox-2 inhibitor , show ability adjunct improve symptom schizophrenia preliminary study . The statin also know decrease C-reactive protein ( CRP ) , show SMRI-funded study elevate study individual schizophrenia . Fan et al ( 2007 ) demonstrate small study patient schizophrenia high normal level CRP ( &gt; 0.50 mg/dl ) associate marked negative symptom higher total PANSS score . Ondansetron serotonin ( 5-HT3 ) receptor antagonist generic widely use prevent nausea vomit patient receive chemotherapy cancer . GSK small study antipsychotic 1980s . Since , several small study suggest effective adjunct drug improve symptom schizophrenia . Statins widely use schizophrenia sufferer , particularly take second generation antipsychotic , treat hypercholesterolemia . Both drug well tolerated side effect profile well understood . We propose conduct feasibility study patient chronic schizophrenia explore adjunct use simvastatin ondansetron positive , negative general psychopathology comparison treatment usual ( TAU ) 12 week period .</brief_summary>
	<brief_title>Role Anti-Inflammatory Agents Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>1 . Diagnostic Statistical ManualIV ( DSMIV ) diagnosis schizophrenia , schizoaffective disorder , psychosis otherwise specify schizophreniform disorder 2. competent willing give inform consent 3. stable medication 4 week prior baseline 4. able take oral medication likely complete require evaluation 5. female participant child bear age must willing use adequate contraceptive duration study , , willing pregnancy test pre treatment ten weekly interval study medication . 1 . Relevant medical illness [ renal hepatic ] opinion investigator 2. history high alcohol intake 3. change psychotropic medication within previous six week 4. diagnosis substance abuse ( except nicotine caffeine ) dependence within last three month accord DSMIV criterion 5. pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Anti inflammatory</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Simvastatin</keyword>
	<keyword>ondansetron</keyword>
</DOC>